Status:
COMPLETED
Locally Delivered 1% Metformin Gel in Peri-implantitis
Lead Sponsor:
King Saud University
Conditions:
Peri-Implantitis
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
This study evaluates the efficacy of 1% local metformin gel in deep periimplant pockets of type 2 diabetes mellitus patients. Half of the participants will receive 1% metformin gel with manual debride...
Detailed Description
Metformin is an oral hypoglycemic drug categorized under biguanide and are considered the most efficient agents widely used in the treatment of type 2 diabetes mellitus.The general clinical benefits o...
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus patients.
- Patients with peri-implantitis
Exclusion
- History of any other systemic diseases
- Cigarette smokers
- Smokeless tobacco users
- Patients who underwent scaling in the last 1 year
- Patients who took antibiotics in tje past 6 months
Key Trial Info
Start Date :
March 15 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 24 2017
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT03312582
Start Date
March 15 2015
End Date
July 24 2017
Last Update
October 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.